Financial statements Pharmacy Research Institute
Balance sheet data of PHARMACY RESEARCH INSTITUTE
|
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 2 284 303,30 | 2 414 958,13 | 3 420 009,20 | 2 084 408,81 | 2 083 143,13 |
| A. Fixed assets | 0,00 | 0,00 | 1 397 369,20 | 227 349,94 | 64 849,94 |
| B. Current assets | 2 284 303,30 | 2 414 958,13 | 2 022 640,00 | 1 857 058,87 | 2 018 293,19 |
| C. Share capital contributions (basic funds) | - | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | - | - | - | - | - |
| Total liabilities | 2 284 303,30 | 2 414 958,13 | 3 420 009,20 | 2 084 408,81 | 2 083 143,13 |
| A. Equity | 2 284 081,90 | 2 275 218,13 | 2 195 596,05 | 1 157 715,49 | 1 281 070,09 |
| B. Liabilities and provisions for liabilities | 221,40 | 139 740,00 | 1 224 413,15 | 926 693,32 | 802 073,04 |
| I. Long-term liabilities | - | - | - | - | - |
| II. Short-term liabilities | - | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.